These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24101102)

  • 1. Prevention: Polypills for cardiovascular prevention: a step forward?
    Sanz G; Fuster V
    Nat Rev Cardiol; 2013 Dec; 10(12):683-4. PubMed ID: 24101102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress with the polypill?
    Gaziano JM
    JAMA; 2013 Sep; 310(9):910-1. PubMed ID: 24002274
    [No Abstract]   [Full Text] [Related]  

  • 3. ACP Journal Club. Fixed-dose combination pills reduced SBP and LDL-C in patients with, or at high risk for, cardiovascular disease.
    Shekelle P
    Ann Intern Med; 2013 Dec; 159(12):JC9. PubMed ID: 24343414
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination pill for cardiovascular disease.
    Carey M
    JAMA; 2014 Jan; 311(1):93. PubMed ID: 24381971
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination pill for cardiovascular disease.
    Tsujimoto T; Yamamoto-Honda R
    JAMA; 2014 Jan; 311(1):92-3. PubMed ID: 24381970
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination pill for cardiovascular disease--reply.
    Thom S; Rodgers A
    JAMA; 2014 Jan; 311(1):93-4. PubMed ID: 24381972
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial.
    Thom S; Poulter N; Field J; Patel A; Prabhakaran D; Stanton A; Grobbee DE; Bots ML; Reddy KS; Cidambi R; Bompoint S; Billot L; Rodgers A;
    JAMA; 2013 Sep; 310(9):918-29. PubMed ID: 24002278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polypill is the solution to the pharmacological management of cardiovascular risk: yes.
    Elley CR
    J Prim Health Care; 2009 Sep; 1(3):232-4. PubMed ID: 20690388
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk.
    Lafeber M; Spiering W; Visseren FL; Grobbee DE; Bots ML; Stanton A; Patel A; Prabhakaran D; Webster R; Thom S; Rodgers A;
    Eur J Prev Cardiol; 2017 Jun; 24(9):951-961. PubMed ID: 28436727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed-dose combination therapy (polypill) for the prevention of cardiovascular disease.
    Huffman MD; de Cates AN; Ebrahim S
    JAMA; 2014 Nov; 312(19):2030-1. PubMed ID: 25399279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trial.
    Singh K; Crossan C; Laba TL; Roy A; Hayes A; Salam A; Jan S; Lord J; Tandon N; Rodgers A; Patel A; Thom S; Prabhakaran D
    Int J Cardiol; 2018 Jul; 262():71-78. PubMed ID: 29622506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined use of polypill components in patients with type 2 diabetes mellitus.
    Janssen VE; Visseren FL; de Boer A; Grobbee DE; Westerink J; van der Graaf Y; Lafeber M;
    Eur J Prev Cardiol; 2018 Sep; 25(14):1523-1531. PubMed ID: 30033753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A polypill is the solution to the pharmacological management of cardiovascular risk: no.
    Toop L
    J Prim Health Care; 2009 Sep; 1(3):234-6. PubMed ID: 21534329
    [No Abstract]   [Full Text] [Related]  

  • 14. Strengths and Limitations of Using the Polypill in Cardiovascular Prevention.
    Roy A; Naik N; Srinath Reddy K
    Curr Cardiol Rep; 2017 May; 19(5):45. PubMed ID: 28425033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countries.
    Webster R; Patel A; Selak V; Billot L; Bots ML; Brown A; Bullen C; Cass A; Crengle S; Raina Elley C; Grobbee DE; Neal B; Peiris D; Poulter N; Prabhakaran D; Rafter N; Stanton A; Stepien S; Thom S; Usherwood T; Wadham A; Rodgers A;
    Int J Cardiol; 2016 Feb; 205():147-156. PubMed ID: 26736090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypill with or without Aspirin in Persons without Cardiovascular Disease.
    Yusuf S; Joseph P; Dans A; Gao P; Teo K; Xavier D; López-Jaramillo P; Yusoff K; Santoso A; Gamra H; Talukder S; Christou C; Girish P; Yeates K; Xavier F; Dagenais G; Rocha C; McCready T; Tyrwhitt J; Bosch J; Pais P;
    N Engl J Med; 2021 Jan; 384(3):216-228. PubMed ID: 33186492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular polypill in high risk patients].
    Lafeber M; Spiering W; Bots ML; de Valk V; Visseren FL; Grobbee DE
    Ned Tijdschr Geneeskd; 2011; 155(44):A3070. PubMed ID: 22067559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors.
    Malekzadeh F; Marshall T; Pourshams A; Gharravi M; Aslani A; Nateghi A; Rastegarpanah M; Khoshnia M; Semnani S; Salahi R; Thomas GN; Larijani B; Cheng KK; Malekzadeh R
    Int J Clin Pract; 2010 Aug; 64(9):1220-7. PubMed ID: 20653798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk.
    Patel A; Cass A; Peiris D; Usherwood T; Brown A; Jan S; Neal B; Hillis GS; Rafter N; Tonkin A; Webster R; Billot L; Bompoint S; Burch C; Burke H; Hayman N; Molanus B; Reid CM; Shiel L; Togni S; Rodgers A;
    Eur J Prev Cardiol; 2015 Jul; 22(7):920-30. PubMed ID: 24676715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypill Strategy in Secondary Cardiovascular Prevention.
    De la Rosa A; Arrington K; Desai R; Acharya PC
    Curr Cardiol Rep; 2024 May; 26(5):443-450. PubMed ID: 38557814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.